I don't know what's in the clauses. I've just seen what's being negotiated. I'm assuming the government will be resisting some. Some are put up just to trade away with.
Certainly, we're under pressure from both the United States and Europe to increase patent rights, especially in the pharmaceutical sector. There's no evidence that this will benefit Canadian innovation. It will likely cost us.
The question then becomes whether there are trade-offs that more than compensate for that loss. If we have patent term extension, it means we'll be paying higher prices for longer, so it will cost more to the Canadian system. Is that justified; can we offset it by other things? I don't know.
But in terms of intellectual property itself, are you asking me whether there is a Canadian justification? The answer is no.